SUMO negatively regulates BACE expression

Neuroendocrinology Letters

Volumn 32, Issue 3, 2011, Pages 313-316

  Fang, Hui ^a,b   Du, Xin ^a,b   Meng, Fan Tao ^a,b   Zhou, Jiang Ning ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Alzheimer's disease; BACE; Mithramycin A; SP1; SUMO

Indexed keywords

BETA SECRETASE; SUMO 1 PROTEIN; SUMO 3 PROTEIN; TRANSCRIPTION FACTOR SP1;

ARTICLE; GENE ACTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUMOYLATION;

EID: 80051979450     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, et al. (2001 ) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci. 4(3): 233-234. (Pubitemid 32194867)
2. Christensen MA, Zhou W, Qing H, Lehman A, Philipsen S, Song W (2004) Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. Mol Cell Biol. 24(2): 865-874. (Pubitemid 38057936)
3. Dorval V, Fraser PE (2006) Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J Biol Chem. 281(15): 9919-9924. (Pubitemid 43864524)
4. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol. 59(9): 1381-1389. (Pubitemid 35014802)
5. Gill G (2004) SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 18(17): 2046-2059.
6. Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, et al. (2004) A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet. 36(8): 837-841. (Pubitemid 39014100)
7. Johnson ES (2004) Protein modification by SUMO. Annu Rev Biochem. 73: 355-382.
8. Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, et al. (2004) Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci U S A. 101(10): 3632-3637. (Pubitemid 38338246)
9. Li Y, Wang H, Wang S, Quon D, Liu YW, Cordell B (2003) Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc Natl Acad Sci USA. 100(1): 259-264. (Pubitemid 36078062)
10. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, ef al. (2001) Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci. 4(3): 231-232.
11. Potter H, Dressier D (2000) The potential of BACE inhibitors for Alzheimer's therapy. Nat Biotechnol. 18(2): 125-126. (Pubitemid 30091164)
12. Roggo, S. (2002). "Inhibition of BACE, a promising approach to Alzheimer's disease therapy." Curr Top Med Chem 2(4): 359-370.
13. Swaab DF, Bao AM (2011) (Re-)activation of neurons in aging and dementia: lessons from the hypothalamus. Exp Gerontol. 46(2-3): 178-184.
14. van de Nes JA, Kamphorst W, Ravid R, Swaab DF (1993) The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer's disease patients. Brain. 116(Pt 1): 103-115. (Pubitemid 23087037)
15. Vassar R (2001). The beta-secretase, BACE: a prime drug target for Alzheimer's disease. J Mol Neurosci. 17(2): 157-170.
16. Vassar R, Bennett DB, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, etal. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 286(5440): 735-741.
17. Zhang YQ, Sarge KD (2008) Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels. Biochem Biophys Res Commun. 374(4): 673-678.